Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Human Ovarian Cancer Cell Line
Email alerts
Human Ovarian Cancer Cell Line
Enhanced anti-tumor effects of the PD-1/PD-L1 blockade by combining a highly absorptive form of NF-kB/STAT3 inhibitor curcumin
Taeko
Hayakawa
,
Juri
Sugiyama
,
Tomonori
Yaguchi
,
Atsushi
Imaizumi
,
Yutaka
Kawakami
Journal for ImmunoTherapy of Cancer
Dec 2014,
2
(Suppl 3)
P210;
DOI:
10.1186/2051-1426-2-S3-P210
High-throughput characterization of the ovarian cancer HLA peptidome
Andrea
Patterson
,
Wilfried
Bardet
,
Curtis
McMurtrey
,
Saghar
Kaabinejadian
,
Ken
Jackson
,
William
Hildebrand
Journal for ImmunoTherapy of Cancer
Dec 2014,
2
(Suppl 3)
P139;
DOI:
10.1186/2051-1426-2-S3-P139
Special collections
COVID-19
(44)
Editor's choice
JITC
Basic Tumor Immunology
(531)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(930)
Commentary/Editorials
(139)
Computational I-O
(4)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(53)
Guidelines and Consensus Statements
(50)
Imaging and Immunotherapy
(8)
Immune Cell Therapies and Immune Cell Engineering
(208)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(401)
Liquid Biopsies
(9)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(142)
Reviews
(238)
Open access
(4834)
Press releases